Effect of thyroid failure on the pituitary-adrenal axis.
D000293:Adolescent; D000311:Adrenal Glands / Q000187:drug effects; D000324:Adrenocorticotropic Hormone; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007273:Injections, Intramuscular; D008239:Lysine; D008297:Male; D008797:Metyrapone; D008875:Middle Aged; D009230:Myxedema / Q000188:drug therapy / Q000503:physiopathology*; D010902:Pituitary Gland / Q000187:drug effects; D010912:Pituitary-Adrenal Function Tests; D010913:Pituitary-Adrenal System / Q000502:physiology*; D013268:Stimulation, Chemical; D013974:Thyroxine / Q000627:therapeutic use; D014667:Vasopressins
D014667:Vasopressins; D000324:Adrenocorticotropic Hormone; D008239:Lysine; D013974:Thyroxine; D006854:Hydrocortisone; D008797:Metyrapone